Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by Jennifer2020on Jan 09, 2022 6:20am
546 Views
Post# 34297217

MMJ Sector

MMJ Sector-TBP got mistaken as a pot producer where in Canada there is a glut of production. 

-The Bull Market in the U.S. that was expected with Biden voted in and promising legalisation hasn't materialized yet due to the dysfunctional U.S. system .

-TBP is actually a pharma / health care play, not a pot producer

-To make matters worse MGMT thought tax loss season kicking off in Dec wouldn't stop them from trying to raise cash  They further spooked people by cancelling one ATM offering and replacing it days later with another one without explaining the purpose of the switch was to "squeeze" 33 Canaccord out of the picture.

-Mission accomplished, Canaccord is out and the two quality book runners took the whole reduced offering to keep the lights on until Reduvo market launch or other developments.   This whole fiasco was a gift to friends and family along with myself to get cheap shares. 

-The winner of the award for "Best Bash 2021" is this little fella whose subtle query/soft bash was perfectly timed:

The StockTalk Cannabis Report: Dec 3, 2021

Comments

 
Is that hedgefund still milking the sector though?
(27)
December 3, 2021



 




<< Previous
Bullboard Posts
Next >>